The central role of magnesium deficiency in Tourette's syndrome: Causal relationships between magnesium deficiency, altered biochemical pathways and symptoms relating to Tourette's syndrome and several reported comorbid conditions

Medical Hypotheses

Volumn 58, Issue 1, 2002, Pages 47-60

  Grimaldi, B L ^a  

^a NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DRUG; KYNURENINE; MAGNESIUM; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; PYRIDOXINE; SUBSTANCE P;

ALLERGY; ANXIETY NEUROSIS; ASTHMA; ATTENTION DEFICIT DISORDER; AUTISM; AUTOIMMUNE DISEASE; AUTOMUTILATION; BRUXISM; COMORBIDITY; COPROLALIA; COPROPRAXIA; DEPRESSION; DRUG EFFICACY; DRUG INDUCED DISEASE; ENVIRONMENTAL FACTOR; GENETIC ASSOCIATION; GILLES DE LA TOURETTE SYNDROME; HEART ARRHYTHMIA; HUMAN; HYPERESTHESIA; MAGNESIUM DEFICIENCY; MEDICAL LITERATURE; MIGRAINE; NEUROLOGIC DISEASE; OBSESSION; PATHOGENESIS; PRIORITY JOURNAL; RAGE; RESTLESS LEGS SYNDROME; REVIEW; SEIZURE; SIGNAL TRANSDUCTION; STARTLE EPILEPSY; SYMPTOM;

EID: 0036172329     PISSN: 03069877     EISSN: None     Source Type: Journal    
DOI: 10.1054/mehy.2001.1447     Document Type: Article

References (219)

1. Tourette's disorder and related problems: A review and update
2. Tics and Gilles de la Tourette syndrome
3. Tourette syndrome: Phenomenology, pathophysiology, genetics, epidemiology and treatment
4. Tourette's Syndrome. Part I: Definition and diagnosis and Tourette's syndrome. Part II: Contemporary approaches to assessment and treatment
5. Gilles de la Tourette Syndrome
6. Differential effects of transdermal nicotine on microstructured analyses of tics in Tourette's syndrome: An open study
7. Severe motor tics causing cervical myelopathy in Tourette's syndrome
8. Tourette syndrome: Clinical and psychological aspects of 250 cases
9. Sensory tics in Tourette's syndrome
10. Tourette's syndrome in patients referred for allergy evaluation
11. Sensory experience as a trigger in Gilles de la Tourette's syndrome
12. Sensory phenomena in Tourette's syndrome
13. Sensory phenomena associated with Gilles de la Tourette's syndrome
14. The biochemistry of Tourette's syndrome
15. Gilles de la Tourette syndrome
16. Multiple tic syndrome (Gilles de la Tourette's syndrome)
17. Neuropsychiatric disorders of childhood: Tourette's syndrome as a model
18. Controlled stimulant treatment of ADHD and comorbid Tourette's syndrome: Effects of stimulant and dose
19. Considerations of natural history and pathophysiology in the psychopharmacology of Tourette's syndrome
20. Tics and dyskinesias associated with stimulant treatment in attention-deficit hyperactivity disorder
21. Gilles de la Tourette's syndrome: Tics and central nervous system stimulants in twins and nontwins
22. Stimulant medications precipitate Tourette's syndrome
23. Gilles de la Tourette's syndrome. Familial occurrence and precipitation by methylphenidate therapy
24. Exacerbation of tics by prednisolone
25. Significant linkage for Tourette syndrome in a large French Canadian family
26. A complete genome screen in sib-pairs affected with the Gilles de la Tourette syndrome
27. Identification of genetic markers associated with Gilles de la Tourette syndrome in an Afrikaner population
28. Tourette's disorder and related problems: A review and update
29. The early course of the Tourette's syndrome clinical spectrum
30. Tourette syndrome and autistic disorder: A significant relationship
31. Fluvoxamine treatment of coincident autistic disorder and obsessive-compulsive disorder: A case report
32. Attention-deficit hyperactivity in adults
33. Role of genetic factors in human sexual behavior based on studies of Tourette syndrome and ADHD probands and their relatives
34. Tourette syndrome. Coprolalia and other coprophenomena
35. Obsessive-compulsive disorder with and without tics in an epidemiological sample of adolescents
36. Stimulus induced behaviours in Tourette's syndrome
37. Sensory phenomena associated with Gilles de la Tourette's syndrome
38. A controlled study of Tourette syndrome. I. Attention-deficit disorder, learning disorders, and school problems
39. Examining the evidence for anxiety-related cognitive biases in obsessive-compulsive disorder
40. Enhanced stress responsitivity of Tourette syndrome patients undergoing lumbar puncture
41. Tourette's syndrome and psychopathology in a child psychiatry setting
42. Rage attacks in children and adolescents with Tourette's disorders: A pilot study
43. Paroxetine treatment of episodic rages associated with Tourette's disorder
44. Self-injurious behaviour in retarded children: Clinical phenomena and biological mechanisms
45. Asthma, allergies and TS Tourette Syndrome Association Inc.
46. Association of allergy with Tourette's syndrome
47. Attention deficit disorder and allergy: A neurochemical model of the relation between the illnesses
48. Foods and additives are common causes of the attention deficit hyperactive disorder in children
49. Neuropharmacological evaluation of movement disorders that are adverse reactions to specific foods
50. Allergy and Tourette's syndrome
51. Tourette's syndrome and migraine
52. Periodic limb movements during sleep are a frequent finding in patients with Gilles de la Tourette's syndrome
53. Further studies on periodic limb movement disorder and restless legs syndrome in children with attention deficit hyperactivity disorder
54. Case study: A new infection-triggered, autoimmune subtype of pediatric OCD and Tourette's syndrome
55. Identification of children with pediatric autoimmune neuropsychiatric disorders associated with streptococcal infections by a marker associated with rheumatic fever
56. Genetic factors in substance abuse based on studies of Tourette Syndrome and ADHD probands and relatives II. Alcohol abuse
57. New experimental and clinical data on the relationship between magnesium and sport
58. Neurotic neuromuscular and autonomic nervous form of magnesium imbalance
59. Magnesium, stress and neuropsychiatric disorders
60. Central nervous system magnesium deficiency
61. Physiological correlates of abnormal behaviors in magnesium-deficient rats
62. Bruxism and magnesium, my Clinical experiences since 1980
63. Interrelationship of magnesium and estrogen in cardiovascular and bone disorders, eclampsia, migraine and premenstrual syndrome
64. Migraine treatment by oral magnesium intake and correction of the irritation of buccofacial and cervical muscles as a side effect of mandibular imbalance
65. Bruxism and magnesium. Literature review and case reports
66. Bruxism and magnesium, my clinical experiences since 1980
67. Clinical, EEG, electromyographic and 101 polysomnographic studies in restless legs syndrome caused by 102 magnesium deficiency
68. Magnesium therapy for periodic leg movements-related insomnia and restless legs syndrome: An open pilot study
69. Intracellular (Polymorphonuclear) magnesium content in patients with bronchial asthma between attacks
70. Magnesium, stress and neuropsychiatric disorders
71. Physiological correlates of abnormal behaviours in magnesium-deficient rats
72. Various neurophysiological aspects of examination of children with Gilles de la Tourette's syndrome
73. Dental treatment of patients with Gilles de la Tourette's syndrome
74. Tourette's syndrome associated with restless legs syndrome and akathisia in a family
75. Gilles de la Tourette syndrome associated with epileptiform discharges; report of three cases
76. Role of magnesium in the pathogenesis and treatment of migraines
77. Aromatic amines (serotonin and histamine) and magnesium deficiency in the rat
78. Magnesium and immune function: An overview
79. Changes in histamine and white blood cells in the blood, spleen and thymus of magnesium deficient rat
80. Recent data on mitral valve prolapse and magnesium deficit
81. Assessment of magnesium levels in children with attention deficit hyperactivity disorder (ADHD)
82. The effect of deficiency of selected bioelements on hyperactivity in children with certain specified mental disorders
83. The effects of magnesium physiological supplementation on hyperactivity in children with attention deficit disorder (ADHD). Positive response to magnesium oral loading test
84. Hereditary isolated renal magnesium loss maps to chromosome 11q23
85. Neurogenic peptides and the cardiomyopathy of magnesium-deficiency: Effects of substance P-receptor inhibition
86. Immunoregulation by neuropeptides in magnesium deficiency: Ex vivo effect of enhanced substance P production on circulating T lymphocytes from magnesium-deficient mice
87. Enhanced NO production during Mg deficiency and its role in mediating red blood cell glutathione loss
88. On kynureninase activity
89. Increased plasma kynurenine and its relationship to neopterin and tryptophan In Tourette's syndrome
90. Caffeine-induced anxiety and increase of kynurenine concentration in plasma of healthy subjects: A pilot study
91. On kynureninase activity
92. Biochemical mechanisms affecting susceptibility to noise-induced hearing loss
93. Enhanced stress responsitivity of Tourette syndrome patients undergoing lumbar puncture
94. Cerebrospinal fluid biogenic amines in obsessive compulsive disorder, Tourette's syndrome, and healthy controls
95. The interaction of some kynurenine pathway metabolites with 5-hydroxytryptophan and 5-hydroxytryptamine
96. Kynurenine may directly interact with GABA receptors in rat brain
97. Excitatory effects of kynurenine and its metabolites, amino acids and convulsants administered into brain ventricles: Differences between rats and mice
98. Amino acid neurotransmitters
99. Clonidine and clonazepam in Tourette syndrome
100. The use of benzodizepines in obsessive compulsive disorder and Tourette's syndrome
101. GABAergic attenuation of cocaine-induced dopamine release and locomotor activity
102. Association of Tourette-like syndrome with ofloxacin
103. Intraventricular administration of I-kynurenine and kynuramine facilitates lordosis in the female rat
104. Effect of magnesium deficiency on vitamin B2 and B6 status in the rat
105. Neurogenic peptides and the cardiomyopathy of magnesium-deficiency: Effects of substance P-receptor inhibition
106. Comparison of tryptophan metabolism in vivo and in isolated hepatocytes from vitamin B6 deficient mice
107. L-kynurenine: Its synthesis and possible regulatory function in brain
108. Blood serotonin and tryptophan in Tourette syndrome
109. Exclusion of the 5-HT1A serotonin neuroreceptor and tryptophan oxygenase genes in a large British kindred multiply affected with Tourette's syndrome, chronic motor tics, and obsessive-compulsive behavior
110. The Role of Transaminations in Pharmacological Effects of Indole-3-Pyruvic Acid
111. Vitamin B6 modulates transcriptional activation by multiple members of the steroid hormone receptor superfamily
112. Modulation of steroid receptor-mediated gene expression by vitamin B6
113. Comparison of tryptophan metabolism in vivo and in isolated hepatocytes from vitamin B6 deficient mice
114. Alterations in brainstem alpha 2 adrenoreceptor activity in pryidoxine-deficient rat model of hypertension
115. Vitamin B-6 depletion followed by repletion with animal- or plant-source diets and calcium and magnesium metabolism in young women
116. In vivo assessment of prevention of white-noise-induced siezure in magnesium-deficient rats by N-methyl-D-aspartate receptor blockers
117. Neurobiology. Taking apart NMDA Receptors
118. Unilateral block of NMDA receptors in the amygdala prevents predator stress-induced lasting increases in anxiety-like behavior and unconditioned startle - Effective hemisphere depends on the behavior
119. Kynurenine metabolites of tryptophan: Implications for neurologic diseases
120. Biochemical studies on AIDS dementia complex-possible contribution of quinolinic acid during brain damage
121. Glutametergic drugs exacerbate symptomatic behavior in a transgenic model of comorbid Tourette's syndrome and obsessive-compulsive disorder
122. Induction of indoleamine 2, 3-dioxygenase in tumor cells transplanted into allogeneic mouse: Interferon-gamma is the inducer
123. Hippocampal kynurenines as etiological factors in seizure disorders
124. The role of nitrogen oxide in migraine attack
125. Activation of N-methyl-D-aspartate receptors in the feline retrorubral nucleus elicits orofacial dyskinesia
126. Tourette syndrome: Prediction of phenotypic variation in monozygotic twins by caudate nucleus D2 receptor binding
127. The pharmacology of native N-methyl-D-aspartate receptor subtypes: Different receptors control the release of different striatal and spinal transmitters
128. Glutamatergic regulation of haloperidol-induced c-fos expression in the rat striatum and nucleus accumbens
129. Role of NMDA glutamate receptors in regulating D2 dopamine-dependent fos induction in the rat striatopallidal pathway
130. Molecular approaches to child psychopathology
131. Immunoregulation by neuropeptides in magnesium deficiency: Ex vivo effect of enhanced substance P production on circulating T lymphocytes from magnesium-deficient mice
132. Research on Tachykinins: Clinical Trends
133. Selective neurokinin NK1 and NK2 receptor agonists infused in the substantia nigra of the rat increase vacuous chewing
134. Striatal substance P cell clusters coincide with the high density terminal zones of the discontinuous nigrostratal dopaminergic projection system in the cat: A study by combined immunohistochemistry and autoradiographic axon-tracing
135. Dopamine, serotonin and tachykinin in self-injurious behavior
136. Distinct mechanism for antidepressant activity by blockade of central substance P receptors
137. Effect of tachykinin receptor inhibition in the brain on cardiovascular and behavioral responses to stress
138. Testosterone regulates substance P within neurons of the medial nucleus of the amygdala, the bed nucleus of the stria terminalis and the medial preoptic area of the male golden hamster
139. Substance P as an immune modulator of anxiety
140. Anxiolytic action of a neurokinin1 receptor antagonist in the social interaction test
141. Anxiolytic-like action of neurokinin substance P administered systemically or into the nucleus basalis magnocellularis region
142. Evidence that substance P is utilized in medial amygdaloid facilitation of defensive rage behavior in the cat
143. Neuropeptides accentuate interleukin-4 induced human immunoglobuline E Synthesis in vitro
144. Substance P induction of itch- associated response mediated by cutaneous NK1 tachykinin receptors in mice
145. Effect of capsaicin as a neuropeptide-releasing substance on sneezing reflex in a type 1 allergic animal model
146. Sensory neurophysiology of the cough reflex
147. Distribution and quantity of neuroendocrine markers in allergic rhinitis
148. Substance P induces degranulation of mast cells and leukocyte adhesion to venular endothelium
149. Seasonal fluctuations of substance P and vasoactive intestinal peptide concentrations in nasal secretions of patients with nasal allergy to Japanese cedar pollen
150. Inhibitory effects of Substance P and carbachol on the saturable sodium-dependent uptake process myo-inositol in rat parotid gland
151. Decreased myo-inositol uptake is associated with reduced bradykinin-stimulated phosphatidylinositol synthesis and diacylglycerol content in cultured neuroblastoma cells exposed to L-fucose
152. Magnesium depletion impairs myocardial carbohydrate and lipid metabolism and cardiac bioenergietics and raises myocardial calcium content in-vivo: Relationship to etiology of cardiac diseases
153. Phosphoinositides as regulators in membrane traffic
154. VII International Union of Pharmacology classification of receptors for 5-hydroxytryptamine (serotonin)
155. Efficacy and tolerability of serotonin transport inhibitors in obsessive-compulsive disorder
156. Immunoregulation by neuropeptides in magnesium deficiency: Ex vivo effect of enhanced substance P production on circulating T lymphocytes from magnesium-deficient mice
157. Increased plasma kynurenine and its relationship to neopterin and tryptophan in Tourette's syndrome
158. Plasma increase of interleukin-12 and interferon-gamma. Pathological significance in autism
159. Th1- and Th2- like cytokines in CD4+ and CD8+ T cells in autism
160. Cerebrospinal fluid cytokines in pediatric neuropsychiatric disease
161. Circulation lymphocyte subsets in obsessive compulsive disorder, major depression and normal controls
162. Audiogenic seizures in magnesium-deficient mice: Effects of magnesium pyrrolidone-2-carboxylate, magnesium acetyltaurinate, magnesium chloride and vitamin B-6
163. Subcutaneously applied magnesium protects reliably against quinolinate-induced N-methyl-D-aspartate (NMDA)-mediated neurodegeneration and convulsions in rats: Are there therapeutical implications
164. Protective effect of Crassostrea gigas extract on audiogenic seizures in magnesium deficient mice
165. Mg2+ protects against PCP-induced cerebrovasospasms and vascular damage in rat brain
166. Brain damage and myocardial dysfunction: Protective effects of magnesium in the newborn pig
167. Treatment of Tourette's syndrome with calcium antagonists
168. Role of magnesium in the pathogenesis and treatment of migraines
169. The effect of deficiency of selected bioelements on hyperactivity in children with certain specified mental disorders
170. Controversies in the treatment of autistic children: Vitamin and drug therapy
171. Comparison of tryptophan metabolism in vivo and in isolated hepatocytes from vitamin B6 deficient mice
172. Effects of Tryptophan 2, 3-Dioxygenase Inhibitors in the Rat
173. Tryptophan transport into the liver of Vitamin B6-deficient rats
174. Nicotinamide, inosine and hypoxanthine, putative endogenous ligands of the benzodiazepine receptor, opposite to diazepam are much more effective against kynurenine-induced seizures than against pentylenetetrazol- induced seizures
175. A double blind randomised placebo controlled trial of hexopal in primary Raynoud's disease
176. Magnesium content of erythrocytes in patients with vasospasic angina
177. Clinical syndromes with vasoconstrictor response
178. L-trytophan-induced eosinophilia-myalgia syndrome. II. Partial correction of abnormal tryptophan metabolism by pyridoxine
179. Purification and characterization of metallothionein and its activation of pyridoxal phosphokinase in trout (Salmo gairdneri) brain
180. Persistent Amphetamine-Induce Compulsive Rituals: Response to Pyridoxine (B6)
181. Gilles de la Tourette syndrome. Interactions with other neuropsychiatric disorders
182. Mg deficiency induces mineral content changes and oxidative stress in rats
183. Impairment of ascorbic acid synthesis in liver extracts of magnesium-deficient rats
184. Enhanced NO production during Mg deficiency and its role in mediating red blood cell glutathione loss
185. Magnesium deficiency-induced cardiomyopathy: Protection by vitamin E
186. Cytokines, neuropeptides, and reperfusion injury during magnesium deficiency
187. Vitamin E treatment of tardive dyskinesia
188. Tardive dyskinesia, lipid peroxidation, and sustained amelioration with vitamin E treatment
189. The specificity of proanthocyanidin-protein interactions
190. Inhibition by nicotinamide of antigen-induced histamine release from mouse peritonial mast cells
191. Effect of pyridoxine on histamine liberation and degranulation of rat mast cells
192. Inhibitory effects of tannins on hyaluronidase activation and on the degranulation from rat mesentery mast cells
193. Cardioprotective effects of grape seed proanthocyanidin against ischemic reperfusion injury
194. Magnesium depletion impairs myocardial carbohydrate and lipid metabolism and cardiac bioenergietics and raises myocardial calcium content in-vivo: Relationship to etiology of cardiac diseases
195. The use of cholinergic precursors in neuropsychiatric diseases
196. Myo-inositol reduces serotonin (5-HT2) receptor induced homologous and heterologous desensitization
197. Inositol Treatment of Obsessive-compulsive Disorder
198. Inositol treatment in Psychiatry
199. Changes of linoleic acid metabolism and cellular phospholipid fatty acid composition in LLC-PK cells cultured at low magnesium concentrations
200. Loss of delta-6-desaturase activity as a key factor in aging
201. Essential fatty acid metabolism in boys with attention-deficit hyperactivity disorder
202. Lowered omega3 polyunsaturated fatty acids in serum phospholiids and cholesteryl esters of depressed patients
203. Requirements of dietary fats to meet nutritional needs & prevent the risk of atherosclerosis - An Indian perspective
204. Health Benefits of Docosahexaenoic Acid (DHA)
205. Dietary fish oil affects monoaminergic neurotransmission and behavior in rats
206. Red blood cell and tissue phospholipid fatty acid profiles of weanling rats fed infant formula fat blends containing soy and/or corn oil
207. Neurotic, neuromuscular and autonomic nervous form of magnesium imbalance